Pasithea Therapeutics Corp Plunges 11.97% on Investor Sentiment Shift

On April 14, 2025, Pasithea Therapeutics Corp experienced a significant drop of 11.97% in pre-market trading, reflecting a notable decline in investor sentiment.

Pasithea Therapeutics Corp has seen a 17.36% increase over the past five trading days, contributing to a 14.52% gain during the second quarter of 2025. This positive trend suggests that the company's recent performance has been favorable, despite the recent pre-market drop.

Pasithea Therapeutics Corp's market capitalization stands at $1.556 million, with a net income of -$13.905 million. The company's revenue growth and income growth metrics are not available, indicating a need for further financial transparency.